Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Different groups of people—men, women, children, and people of different races or ethnic backgrounds—respond differently to different drugs. Clinical trials are supposed to drive advances in medicine ...
Expanding trial eligibility in FL could improve access to novel therapies and better reflect real-world patient populations. Current trials often exclude older patients and those with poor performance ...
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...
Thirty Japanese men are making medical history. They’re participating in the world’s first human trial of TRG-035, a drug designed to regenerate actual teeth in adults who’ve lost them. After nearly ...
Share on Pinterest Novo Nordisk has announced the cessation of the Evoke trials, looking at whether GLP-1 drugs could help tackle Alzheimer’s. Image credit: NurPhoto/Getty Images Pharmaceutical giant ...
Novo Nordisk has announced the cessation of the Evoke trials, looking at whether GLP-1 drugs could help tackle Alzheimer's. Image credit: NurPhoto/Getty Images Already, these drugs have helped ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results